What demand and pipeline metrics did Amesite (AMST) share for NurseMagic?

Amesite cites approximately 4,200 web visits per day and a steadily growing volume of inbound interest from providers. The company is in advanced discussions with additional organizations representing several thousand more patients in aggregate census, with over 70% of these prospects self-scheduling demos.

Amesite (NASDAQ: AMST) wins 2,700-patient NurseMagic enterprise deployment

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

Amesite Inc. disclosed that its NurseMagic™ AI documentation platform has secured a new enterprise customer with an approximately 2,700-patient census, the company’s largest deployment to date. The customer will roll out NurseMagic™ across its workforce to integrate EMR and EVV workflows and reduce administrative tasks that can consume up to 16 hours per caregiver per week.

The company describes this as a step-change in scale that validates NurseMagic™ as core clinical infrastructure for the non-acute/post-acute market. Management also highlights approximately an 18% reduction in operating spend over the last six quarters, a growing base of paying customers, and digital demand metrics including about 4,200 web visits per day and strong inbound interest from providers.

Positive

Largest enterprise deployment and efficiency gains: Amesite reports a 2,700-patient NurseMagic™ enterprise customer, described as its largest deployment, alongside approximately an 18% reduction in operating spend over six quarters while serving a growing base of paying customers.

Negative

None.

Insights

Amesite highlights its largest NurseMagic deployment and improving operating efficiency metrics.

Amesite reports a new NurseMagic™ enterprise customer covering roughly 2,700 patients, described as its largest deployment and a major validation of its enterprise strategy. The platform supports multiple roles, permissions, EMR and EVV integration, and custom documentation across thousands of patients.

Management states that NurseMagic’s AI-first, configurable design reduces the need for human support and heavy consulting. They attribute this approach to approximately a 18% reduction in operating spend over the last six quarters while serving a growing base of paying customers, framing the deployment as scalable and cost-efficient.

The company also cites about 4,200 daily web visits and advanced discussions with additional organizations representing several thousand aggregate patients, with over 70% of prospects self-scheduling demos. Future filings may clarify how these pipeline indicators convert into contracted deployments and financial results over subsequent reporting periods.

8-K Event Classification

2 items: 8.01, 9.01

2 items

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Key Figures

New enterprise census: 2,700 patients Caregiver admin time: Up to 16 hours/week Operating spend reduction: 18% +5 more

8 metrics

New enterprise census 2,700 patients Size of new NurseMagic enterprise deployment

Caregiver admin time Up to 16 hours/week Administrative burden per caregiver that deployment aims to reduce

Operating spend reduction 18% Approximate reduction over the last six quarters

Daily web traffic 4,200 visits per day Sales and marketing digital engagement for NurseMagic

Documentation time change 20 minutes to 20 seconds Claimed NurseMagic impact on documentation time per task

Target market size $1.5T+ Non-acute/post-acute care segments Amesite aims to serve

Professional coverage Over 100 professions Types of users reportedly using NurseMagic

Geographic reach 50 states, 21 countries Reported NurseMagic usage footprint

Key Terms

enterprise customer, non-acute care, electronic visit verification (EVV), operating spend, +2 more

6 terms

enterprise customer financial

"announced it has secured a new enterprise customer representing an approximately 2,700-patient census"

non-acute care financial

"EMR for non-acute care, today announced it has secured a new enterprise customer"

Non-acute care covers medical and support services for ongoing, routine, or chronic needs rather than emergency or intensive hospital treatment—examples include primary care, rehabilitation, long-term nursing, home health, and outpatient clinics. For investors it matters because this “routine maintenance” side of healthcare tends to have steadier demand, different payment rules and margins, and sensitivity to population aging and regulatory changes, all of which affect revenue predictability and capital planning.

electronic visit verification (EVV) technical

"integrate their EMR, and integrate with their electronic visit verification (EVV) workflow"

A system that records and confirms in-home or remote healthcare visits by capturing who provided the care, when and where it happened, and what services were delivered, often using GPS, timestamps, and electronic signatures. For investors, EVV matters because it affects whether providers get paid, reduces billing errors and fraud risk, and can drive demand for software and devices — think of it as a GPS-enabled time card that protects revenue and compliance.

operating spend financial

"contributed to approximately 18% reduction in operating spend over the last 6 quarters"

unit economics financial

"we expect our automation efficiencies to continue to benefit our unit economics and support margin expansion"

Unit economics analyzes the profitability of a single product or service by comparing the revenue it generates to the costs involved in producing and delivering it. It helps determine whether each sale contributes to overall profit, much like assessing if selling one item covers its production costs and leaves money left over. Investors use this to judge if a business model is sustainable and capable of growth.

HIPAA regulatory

"Built on proprietary AI trained on industry-specific data, NurseMagic™ meets HIPAA regulations"

A U.S. law that sets rules for keeping individuals’ health information private and secure, and for how that information can be shared. Think of it as a mandatory lock-and-key system for medical records that hospitals, insurers, and tech vendors must use. Investors care because failing to follow these rules can lead to big fines, costly remediation, loss of business access to patient data, and reputational damage that can hurt a company’s finances and growth prospects.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Understanding 8-K Material Events →

Available on EDGAR 05/19/2026 - 08:31 AM Accepted by SEC EDGAR 05/19/2026 - 08:30 AM

FAQ

What did Amesite (AMST) announce about its NurseMagic platform in this 8-K?

Amesite announced a new enterprise customer for its NurseMagic™ AI documentation platform, covering an approximately 2,700-patient census. The company describes this as its largest deployment to date and a major milestone in validating its enterprise-focused strategy in non-acute and post-acute care.

How large is the new Amesite (AMST) NurseMagic enterprise deployment?

The new enterprise customer represents an approximately 2,700-patient census, which Amesite calls its largest deployment so far. The rollout will span multiple roles and integrate EMR and electronic visit verification (EVV) workflows across thousands of patients in non-acute care settings.

How does Amesite (AMST) say NurseMagic affects caregiver administrative work?

Amesite states that the NurseMagic™ deployment is expected to significantly reduce administrative burden that can consume up to 16 hours per caregiver per week. By automating documentation and integrating with EMR and EVV systems, the platform aims to streamline workflows for nurses and caregivers.

What operating cost trend did Amesite (AMST) highlight in connection with NurseMagic?

Amesite reports approximately an 18% reduction in operating spend over the last six quarters. Management attributes this to building NurseMagic™ as an AI-first, configurable platform that automates work which historically required significant human support, while supporting a growing base of paying customers.

How does Amesite (AMST) describe the market opportunity for NurseMagic?

Amesite targets what it describes as the $1.5 trillion-plus non-acute and post-acute care segments. NurseMagic™ is positioned as AI-native clinical documentation infrastructure designed to operate at enterprise scale while aiming for cost-efficient execution in this large healthcare market.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 18, 2026

Amesite Inc.

(Exact name of registrant as specified in its charter)

Delaware		001-39553		82-3431718
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

607 Shelby Street

Suite 700 PMB 214

Detroit, MI

48226

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (734) 876-8141

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.0001 per share		AMST		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01 Other Events.

On May 18, 2026, Amesite Inc. issued a press release announcing that it has secured a new enterprise customer representing an approximately 2,700-patient census—its largest deployment to date and a major milestone in validating its enterprise strategy. A copy of the press release is attached hereto as Exhibit 99.1 to this Current Report and is incorporated by reference herein.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.		Description
99.1		Press release dated May 18, 2026
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	AMESITE INC.

Date: May 19, 2026	By:	/s/ Ann Marie Sastry, Ph.D.
	Name:	Ann Marie Sastry, Ph.D.
	Title:	Chief Executive Officer

Exhibit 99.1

Amesite’s NurseMagic™ Wins 2,700-Census Home Care Enterprise Customer

Enterprise Deployment Validates AI-Native Infrastructure Strategy and Proves Scalable, Cost-Efficient Execution in Non-Acute Care

DETROIT, May 18, 2026 (GLOBE NEWSWIRE) — Amesite Inc. (Nasdaq: AMST), developer of the AI-native NurseMagic™ documentation platform and EMR for non-acute care, today announced it has secured a new enterprise customer representing an approximately 2,700-patient census—its largest deployment to date and a major milestone in validating its enterprise strategy.

The customer will deploy NurseMagic™ AI documentation across its workforce to streamline workflows, integrate their EMR, and integrate with their electronic visit verification (EVV) workflow. The deployment is expected to significantly reduce the administrative burden that currently consumes up to 16 hours¹ per caregiver per week.

This win represents a step-function increase in scale, substantially expanding NurseMagic™’s enterprise census footprint and demonstrating the platform’s ability to operate across complex organizations.

Dr. Ann Marie Sastry, Founder and CEO of Amesite, said, “This 2,700-census deployment validates the strength of our architecture. We are supporting multiple roles, layered permissions, EMR and EVV integration, and custom documentation across thousands of patients — without the heavy consulting, technology fees, and custom development that typically drive up pricing from legacy providers. Because NurseMagic™ is AI-first, automated, and configurable, we launch new customers quickly, without weeks or months of onboarding. This achievement reflects the successful transition from an assistive tool to core clinical infrastructure in the $1.5T+^2-7 non-acute/post-acute market. For investors, it demonstrates that our platform scales into enterprise environments while preserving strong economics, even as we continue to maintain fiscal discipline.”

“We executed this deployment with the same financial discipline we have applied across the company over the last several quarters,” said Sarah Berman, Principal Finance and Accounting Officer. “By building NurseMagic™ as an AI-first, configurable platform, we have been able to automate work that historically required significant human support. That approach has contributed to approximately 18% reduction in operating spend over the last 6 quarters, while supporting a growing base of paying customers. As we scale into larger enterprises, we expect our automation efficiencies to continue to benefit our unit economics and support margin expansion over time.”

Madison Bush, Director of Corporate Operations, said “Our sales and marketing flows are delivering approximately 4,200 web visits per day and a steadily growing volume of inbound interest from providers who are actively seeking AI-first alternatives or improvements to legacy systems. We are already engaged in advanced discussions with additional organizations representing several thousand more patients in aggregate census — over 70% of which self-scheduled a demo on our website. Our recently announced major integration has made it easier for enterprises to see how NurseMagic™ fits into their existing infrastructure. Our digital engagement, and the strength of our pipeline gives us confidence that we can meet demand for AI-native, cost-efficient documentation at scale.”

With customers ranging from smaller providers to enterprise organizations with thousands of patient censuses, NurseMagic™ is now proven across the full spectrum of non-acute care operations.

About Amesite Inc.

Amesite (NASDAQ: AMST) is an AI-driven company with an immediate aim to transform the $1.5 trillion non-acute care segments. Its flagship product, NurseMagic™, streamlines documentation for nurses and caregivers, reducing the time required from 20 minutes to just 20 seconds. NurseMagic™ is used by over 100 professions to improve care, enhance operational efficiency and improve financial performance. Built on proprietary AI trained on industry-specific data, NurseMagic™ meets HIPAA regulations while improving accuracy and efficiency. The platform serves B2B and B2C users across 50 states and 21 countries, offering seamless integration into healthcare workflows and translations to over 50 languages.

Forward-Looking Statement

This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company and its business. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “may,” “will,” “should,” “would,” “expect,” “plan,” “believe,” “intend,” “look forward,” and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its business are set forth in the Company’s filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations

ir@amesite.com

Sources

https://www.aacn.org/blog/nursing-documentation-burden-a-critical-problem-to-solve

https://www.grandviewresearch.com/industry-analysis/us-skilled-nursing-facility-market

https://www.ibisworld.com/united-states/industry/home-care-providers/1579/

https://www.grandviewresearch.com/industry-analysis/us-home-healthcare-market-report

https://www.grandviewresearch.com/industry-analysis/us-senior-living-market-report

https://www.grandviewresearch.com/industry-analysis/us-hospice-market

https://www.aaltci.org/news/long-term-care-insurance-news/out-of-pocket-expenditures-for-nursing-home-care-expenditures-to-grow

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

4 documents

Press Releases

EX-99.1 PRESS RELEASE DATED MAY 18, 2026 13.0 KB